Metronidazole vaginal gel
ژل واژینال مترونیدازول
🚻 Genito Urinary System And Sex HormonesVaginal nitroimidazole
Market / country: 🇺🇸 USA
MetroGel-Vaginal (US)
🧮 Dose calculator
Bacterial vaginosis · Regimen source: FDA MetroGel vaginal · Dosage and Administration
- • Each applicator ≈ 37.5 mg metronidazole. FDA MetroGel vaginal · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to metronidazole, parabens or other nitroimidazoles. FDA MetroGel vaginal · Contraindications
- ⛔ Not established in children. FDA MetroGel vaginal · Pediatric Use
Formulations
- 0.75% vaginal gel (5 g applicator) — gel 🇺🇸 USA FDA MetroGel vaginal · Dosage and Administration
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA MetroGel vaginal · Pregnancy: Teratogenic Effects:
“Because animal reproduction studies are not always predictive of human response, and because metronidazole is a carcinogen in rodents, this drug should be used during pregnancy only if clearly needed.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA MetroGel vaginal · Nursing Mothers:
“Because of the potential for tumorigenicity shown for metronidazole in mouse and rat studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA MetroGel vaginal · Pediatric Use:
“Safety and effectiveness in children have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA218485
- DailyMed (FDA label)FDA MetroGel vaginal
- MedlinePlus (NIH)Metronidazole Vaginal
- WHO ATC/DDDG01AF01
- Darooyab (Iran)Metronidazole
🇮🇷 Registered in Iran Darooyab · G-1131/Metronidazole
Dosage forms with Iranian generic codes, per Darooyab.
- 02074 · METRONIDAZOLE 0.75% VAG GEL · ژل واژینال مترونیدازول ۰٫۷۵ درصد
- 01590 · METRONIDAZOLE 0.75%TOP GEL · ژل موضعی مترونیدازول ۰٫۷۵ درصد
- 12496 · METRONIDAZOLE 200MG TAB · قرص مترونیدازول ۲۰۰ میلیگرم
- 00845 · METRONIDAZOLE 250MG TAB · قرص مترونیدازول ۲۵۰ میلیگرم
- 02162 · METRONIDAZOLE 500MG OVULE · مترونیدازول ۵۰۰ میلیگرم اوول
- 12912 · METRONIDAZOLE 500MG VAG SUPP · شیاف مترونیدازول ۵۰۰ میلیگرم
- 00846 · METRONIDAZOLE 500MG VAG TAB · قرص واژینال مترونیدازول ۵۰۰ میلیگرم
- 00843 · METRONIDAZOLE 500MG/100ML VIAL P-BAG · ویال مترونیدازول ۵۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 08243 · METRONIDAZOLE 500MG/100ML VIAL P-BOTTLE · ویال مترونیدازول ۵۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 00844 · METRONIDAZOLE BENZOATE 125MG/5ML 120ML SUSP · سوسپانسیون مترونیدازول بنزوات ۱۲۵ میلیگرم / ۵ میلیلیتر ۱۲۰ میلیلیتر
- 51656 · METRONIDAZOLE 500MG TAB · قرص مترونیدازول ۵۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA MetroGel vaginal · Dosage and AdministrationFDA MetroGel vaginal · ContraindicationsFDA MetroGel vaginal · Pediatric UseFDA MetroGel vaginal · Pregnancy: Teratogenic Effects:FDA MetroGel vaginal · Nursing Mothers:FDA MetroGel vaginal · Pediatric Use:FDA MetroGel vaginal · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1131/Metronidazole
- Clinical review⚠ Unverified